Publishing research using ab2231? Please let us know so that we can cite the reference in this datasheet.

ab2231 has been referenced in 7 publications.

  • Jung CS  et al. Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury. Int J Mol Sci 15:4088-103 (2014). IHC-Fr ; Rat . PubMed: 24663083
  • Ghebremariam YT  et al. FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed Dahl rats. PLoS One 8:e60653 (2013). WB ; Rat . PubMed: 23593273
  • Shao Z  et al. Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. J Am Coll Cardiol 59:1150-8 (2012). WB ; Human . PubMed: 22440215
  • Saratsis AM  et al. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro Oncol 14:547-60 (2012). WB, ICC/IF ; Human . PubMed: 22492959
  • Ghebremariam YT  et al. Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening. J Biomol Screen 17:651-61 (2012). WB ; Human . PubMed: 22460174
  • Ito E  et al. Regulation of myometrial contractivity during pregnancy in the rat: potential role for DDAH. Mol Hum Reprod 15:507-12 (2009). PubMed: 19528264
  • Hasegawa K  et al. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res 101:e2-10 (2007). PubMed: 17601800

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"